Methods and compositions for treating melanoma
US-2024424002-A1 · Dec 26, 2024 · US
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
US8975258B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8975258-B2 |
| Application number | US-201213612451-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 12, 2012 |
| Priority date | Dec 28, 2006 |
| Publication date | Mar 10, 2015 |
| Grant date | Mar 10, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control. The compounds of the invention are orally active.
First claim
Opening claim text (preview).
What is claimed is: 1. A compound of Formula II: wherein, D is selected from the group consisting of O, S, and NR 8 , X, Y, and Z are independently selected from the group consisting of O and N and one of X, Y, and Z is O and the other two of X, Y, and Z are N; J, K, T, and U are each independently selected from the group consisting of C, CH and N; the subscript p…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8975258B2 cover?
- Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control. The compounds of the invention are orally active.
- Who is the assignee on this patent?
- Chen Xin, Cheng Peng, Clemens L Edward, and 10 more
- What technology area does this patent fall under?
- Primary CPC classification A61K31/506. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).